A study for the effect of intakes of a food ingredient on mood state in healthy adults -Randomized, double-blind, placebo-controlled, parallel-group study- - A study for the effect of intakes of a food ingredient on mood state

Kirin Holdings Company, Limited0 sites88 target enrollmentMarch 31, 2023

Conditionsone (Healthy adults)

Overview

Phase: 未知
Intervention: Not specified
Conditions: one (Healthy adults)
Sponsor: Kirin Holdings Company, Limited
Enrollment: 88
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

March 31, 2023

End Date

June 24, 2022

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Kirin Holdings Company, Limited

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•Subjects (1\) with high psychological health as a result of the GHQ28 (2\) who showed significant fluctuations in the measured values of the major endpoints in the two pre\-tests (3\) who continuously consume medicines or foods fortified with the ingredients involved in functionality (4\) who continuously take medicines or health foods to improve their mood, fatigue, stress, or sleep (5\) who regularly engage in activities aimed at improving mood, fatigue, stress, and sleep (6\) who are unable to use the prescribed applications on their smartphones or cooperate with web surveys (7\) whose working days are irregular (8\) whose life is irregular several times during the research period (9\) whose lives are scheduled to undergo major changes during the research period (10\) who are heavy drinker (11\) who are undergoing treatment for, have a history of, or are suspected of having a mental disorder (12\) who are suffering from or aware of sleep\-related illnesses (13\) who have been diagnosed with chronic fatigue syndrome (14\) who may have physical deconditioning due to test foods (15\) who regularly smoke or who started smoking cessation within 12 months (16\) who have donated 200 or 400 mL of whole blood or had a blood transfusion within 3 months prior to the pre\-test (17\) who have participated in other clinical trials within 1 month prior to the pre\-test, or who plan to participate during the study period (18\) who have a disease that requires constant medication (19\) who are judged unsuitable as subjects by the Chief Medical Officer based on the clinical examination values (20\) who are pregnant, lactating, or planning to become pregnant or lactate during the study period (21\) who are judged to be unsuitable as subjects based on their responses to the preliminary questionnaire (22\) who work for a company that develops or manufactures functional foods, either by themselves or by a family member living with them (23\) who are judged unsuitable as subjects by the Chief Medical Officer